Company intelligence / Profile preview

CareNX

Pune, Maharashtra, Indiacarenx.com ↗

Ownership: Private
Employees: ~15
Development stage: Commercial

Overview

Fetosense is a clinically validated and commercialized portable smartphone-based fetal heart monitor that uses AI for real-time interpretation of non-stress test (NST) and cardiotocography (CTG) data. It has demonstrated the ability to identify fetal complications up to 52% earlier and reduce preterm cases by up to 33% across over 500,000 pregnancies screened in six countries. The system is used by more than 3,000 gynecologists and incorporated into India's National Health Mission project implementation plan[2][3][5].

Therapeutic areas: Women's Health
Modalities: DeviceDigital health platform
Industry: Physiological Monitoring

Partnerships

Gujarat state government (India)Society for Innovation and Entrepreneurship (SINE), IIT MumbaiMultiple NGOs/government partners for antenatal care delivery programs

Beyond the preview

Go deeper on CareNX.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CareNX.

Explore the full profile